The IHS Juniors Group members undertook a worldwide survey encompassing 84 countries to evaluate the differing global access to acute and preventive medications for migraine and tension-type headache. For each treatment, participants were asked about availability, type of reimbursement and variability of access within their country.

The results were published recently in Cephalalgia – read the article here.